CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Warsaw, Poland and 209 other locations
medicinal product\]) in patients with advanced or metastasized non-small cell lung cancer (NSCLC) and...
Phase 1
Warsaw, Poland and 37 other locations
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung...
Phase 2
Warszawa, Poland and 138 other locations
PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....
Phase 2
Warszawa, Poland and 126 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Warszawa, Poland and 230 other locations
to determine the efficacy and safety of durvalumab and/or novel oncology therapies, with or without chemotherapy, for first-line Stage IV Non...
Phase 1
Warszawa, Poland and 41 other locations
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the-...
Phase 3
Warszawa, Poland and 238 other locations
In the SAMSON-2 study, the proposed biosimilar HD204 will be compared to its reference product EU-licensed Avastin®. The aim of the study is to demon...
Phase 3
Warszawa, Poland and 17 other locations
of AZD9291 versus a standard of care epidermal growth factor receptor tyrosine kinase inhibitor in patients with locally advanced or Metastatic Non...
Phase 3
Warszawa, Poland and 168 other locations
untreated patients with resectable, early-stage (stage II to IIIA) non-small cell lung cancer (NSCLC)....
Phase 2
Warsaw, Poland and 29 other locations
Clinical trials
Research sites
Resources
Legal